Burstable.Video

Lionheart Health Files Patent for Bioelectric Platform to Boost Peptide Therapies

By Burstable Editorial Team•
Lionheart Health files patent for bioelectric platform boosting peptide delivery by 300%. Technology enhances oral, topical & injectable peptide absorption for longevity applications.

Found this article helpful?

Share it with your network and spread the knowledge!

TLDR

  • Lionheart Health's bioelectric platform could provide a competitive edge by enabling lower peptide doses with up to 300% greater efficacy across multiple delivery methods.
  • The technology uses controlled bioelectric stimulation to enhance transmembrane transport, barrier permeability, and receptor sensitization, improving peptide uptake and biological effectiveness.
  • This innovation could make longevity treatments more accessible and effective, potentially improving healthspan and quality of life for aging populations worldwide.
  • Bioelectric stimulation can boost peptide absorption by up to 300%, turning science fiction into reality for enhanced longevity therapies.
Read original article
Burstable Editorial Team

Burstable Editorial Team

@burstable

Burstable News™ is a hosted solution designed to help businesses build an audience and enhance their AIO and SEO press release strategies by automatically providing fresh, unique, and brand-aligned business news content. It eliminates the overhead of engineering, maintenance, and content creation, offering an easy, no-developer-needed implementation that works on any website. The service focuses on boosting site authority with vertically-aligned stories that are guaranteed unique and compliant with Google's E-E-A-T guidelines to keep your site dynamic and engaging.

WebsiteBlogLinkedInX/Twitter